Abstract
Annual Review of Immunology
Vol. 18:
275-308
(Volume publication date April 2000)
(doi:10.1146/annurev.immunol.18.1.275)
CD8+ T Cell Effector Mechanisms in Resistance to Infection Based on T cell subset depletion studies and the analysis of gene knockout mice, it is evident that CD8+ T cells contribute to resistance against intracellular infections with certain viral, protozoan, and bacterial pathogens. Although they are known primarily for their capacity to kill infected cells, CD8+ T cells elaborate a variety of effector mechanisms with the potential to defend against infection. Microbes use multiple strategies to cause infection, and the nature of the pathogenhost interaction may determine which CD8+ T cell effector mechanisms are required for immunity. In this review, we summarize our current understanding of the effector functions used by CD8+ T cells in resistance to pathogens. Analyses of mice deficient in perforin and/or Fas demonstrate that cytolysis is critical for immunity against some, but not all, infections and also reveal the contribution of cytolysis to the pathogenesis of disease. The role of CD8+ T cell–derived cytokines in resistance to infection has been analyzed by systemic treatment with neutralizing antibodies and cytokine gene knockout mice. These studies are complicated by the fact that few, if any, cytokines are uniquely produced by CD8+ T cells. Thus, the requirement for CD8+ T cell– derived cytokines in resistance against most pathogens remains to be defined. Finally, recent studies of human CD8+ T cells reveal the potential for novel effector mechanisms in resistance to infection. Most recent citing papers (via CrossRef)Quick to remember, slow to forget: rapid recall responses of memory CD8+ T cells Cell Research 20(1):13-23 (2010) Regulating functional cell fates in CD8 T cells Immunologic Research (2009) NK cell-mediated killing of target cells triggers robust antigen-specific T cell-mediated and humoral responses Blood 113(26):6593-6602 (2009) Th17 cells enhance viral persistence and inhibit T cell cytotoxicity in a model of chronic virus infection Journal of Experimental Medicine 206(2):313-328 (2009) Developing an HIV cytotoxic T-lymphocyte vaccine: issues of CD8 T-cell quantity, quality and location Journal of Internal Medicine 265(1):125-137 (2009)
|
|
|
Users who read this review also read:
| Phillip Wong and , Eric G. Pamer Annual Review of Immunology. Volume 21, Page 29-70, Apr 2003 Abstract
| Full Text
| PDF (323 KB)
|
Add to Favorites
| Related | |
| Jennifer E. Smith-Garvin, Gary A. Koretzky, Martha S. Jordan Annual Review of Immunology. Volume 27, Page 591-619, Apr 2009 Abstract
| Full Text
| PDF (505 KB)
|
Add to Favorites
| Related | |
| Federica Sallusto, Jens Geginat, Antonio Lanzavecchia Annual Review of Immunology. Volume 22, Page 745-763, Apr 2004 Abstract
| Full Text
| PDF (209 KB)
|
Add to Favorites
| Related | |
| Matthew A. Williams, Michael J. Bevan Annual Review of Immunology. Volume 25, Page 171-192, Apr 2007 Abstract
| Full Text
| PDF (156 KB)
|
Add to Favorites
| Related | |
|
|